Apimeds Pharmaceuticals US Inc
APUS2.740USD
0.000
Close 11/05, 16:00（ET）Quotes delayed by 15 min
34.46MMarket Cap
LossP/E TTM
More Details of Apimeds Pharmaceuticals US Inc Company
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.
Apimeds Pharmaceuticals US Inc Info
Ticker SymbolAPUS
Company nameApimeds Pharmaceuticals US Inc
IPO dateMay 09, 2025
CEOMr. Erik C. Emerson
Number of employees2
Security typeOrdinary Share
Fiscal year-endMay 09
Address100 Matawan Road
CityMATAWAN
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code07747
Phone18482015010
Websitehttps://www.apimedsus.com/
Ticker SymbolAPUS
IPO dateMay 09, 2025
CEOMr. Erik C. Emerson
Company Executives of Apimeds Pharmaceuticals US Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Erik C. Emerson
Mr. Erik C. Emerson
Chief Executive Officer, Director
Chief Executive Officer, Director
750.00K
--
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
643.88K
+4.63%
Dr. Christopher Kim, M.D.
Dr. Christopher Kim, M.D.
Chairman of the Board, Chief Medical Officer
Chairman of the Board, Chief Medical Officer
277.50K
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Ms. Carol O'Donnell
Ms. Carol O'Donnell
Independent Director
Independent Director
--
--
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Dr. Hankil Yoon, Ph.D.
Dr. Hankil Yoon, Ph.D.
Independent Director
Independent Director
--
--
Mr. Erick Frim
Mr. Erick Frim
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Erik C. Emerson
Mr. Erik C. Emerson
Chief Executive Officer, Director
Chief Executive Officer, Director
750.00K
--
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
643.88K
+4.63%
Dr. Christopher Kim, M.D.
Dr. Christopher Kim, M.D.
Chairman of the Board, Chief Medical Officer
Chairman of the Board, Chief Medical Officer
277.50K
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Ms. Carol O'Donnell
Ms. Carol O'Donnell
Independent Director
Independent Director
--
--
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Wed, Sep 3
Updated: Wed, Sep 3
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Apimeds, Inc.
34.89%
Inscobee, Inc.
16.13%
Dominus IB, Inc
6.36%
Emerson (Erik C)
5.96%
Koo (Jakap)
5.12%
Other
31.53%
Shareholders
Shareholders
Proportion
Apimeds, Inc.
34.89%
Inscobee, Inc.
16.13%
Dominus IB, Inc
6.36%
Emerson (Erik C)
5.96%
Koo (Jakap)
5.12%
Other
31.53%
Shareholder Types
Shareholders
Proportion
Corporation
62.15%
Individual Investor
13.29%
Investment Advisor
0.28%
Investment Advisor/Hedge Fund
0.23%
Hedge Fund
0.13%
Research Firm
0.10%
Other
23.82%
Institutional Shareholding
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
7
93.03K
0.74%
+73.88K
2025Q2
7
9.49M
81.96%
+7.39M
2025Q1
2
2.10M
18.15%
+2.10M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Apimeds, Inc.
4.39M
34.89%
+4.39M
--
May 12, 2025
Inscobee, Inc.
2.03M
16.13%
+544.04K
+36.65%
May 12, 2025
Dominus IB, Inc
800.00K
6.36%
+800.00K
--
May 09, 2025
Emerson (Erik C)
750.00K
5.96%
+750.00K
--
May 16, 2025
Koo (Jakap)
643.88K
5.12%
+28.50K
+4.63%
May 12, 2025
Seed 1 ho
600.00K
4.77%
+600.00K
--
May 09, 2025
Kim (Christopher)
277.50K
2.21%
+277.50K
--
May 16, 2025
The Vanguard Group, Inc.
7.17K
0.06%
--
--
Aug 31, 2025
Geode Capital Management, L.L.C.
11.97K
0.1%
+9.73K
+434.33%
Aug 31, 2025
Citadel Advisors LLC
13.36K
0.11%
+13.36K
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
